PulseAugur
EN
LIVE 06:51:33
ENTITY Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.

Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.

PulseAugur coverage of Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. — every cluster mentioning Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_239447 ·

    LLMs show promise in drug discovery for small-molecule design

    Researchers are exploring the use of large language models (LLMs) for small-molecule design in drug discovery. One approach involves training LLMs on synthetic tasks that generalize to complex molecular optimization pro…